Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Eli Lilly & Co. (NY: LLY)
54.92 USD  -0.22 (-0.40%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Eli Lilly & Co.
 
< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Corgenix Announces Diagnostic Development Agreement with Lilly
Today 6:45 EDT
from Business Wire News Releases
From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients
May 20, 2013
Video shows how those from the medical field bring patient care experience to pharmaceutical career Read More
from PR Newswire
Lilly Oncology to Release New Pipeline Data at ASCO 2013
May 14, 2013
Data from Pipeline Molecules Targeting Key Cancer Pathways to be Presented Read More
from PR Newswire
Lilly Provides Update on CEO Dr. John Lechleiter
May 14, 2013
from PR Newswire
Perfect Trade Setups, How to Play NLY, CHK, WCRX and LLY
May 14, 2013
from Marketwired News Releases
The Straight Truth, Investing in C, LLY, AMZN and FB
May 11, 2013
from Marketwired News Releases
Strategy Behind Our Success, We Get in Early: LLY, COP, GE and EXC
May 10, 2013
from Marketwired News Releases
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
May 10, 2013
from PR Newswire
The Reason It Trades, What's Moving LLY, MBI, REGN and BMY
May 08, 2013
from Marketwired News Releases
Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
May 06, 2013
Retrospective pooled analyses evaluated linagliptin treatment in American Hispanic/Latino people with type 2 diabetes, as well as in people living with type 2 diabetes for at least 10 years Read More
from PR Newswire
Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
May 06, 2013
from PR Newswire
Lilly Declares Second-Quarter 2013 Dividend
May 06, 2013
from PR Newswire
Critical Alerts For Microsoft, Suncor Energy, Eli Lilly, TRW Automotive, and Embraer Released By InvestorsObserver
May 02, 2013
from PR Newswire
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
May 02, 2013
The SGLT disease education campaign provides resources for healthcare professionals about the role of sodium glucose co-transporters in maintaining blood sugar balance Read More
from PR Newswire
The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies – Big or Small
May 01, 2013
from Business Wire News Releases
The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small
May 01, 2013
How-to video, English and Spanish checklists available to aid advance planning Read More
from PR Newswire
Lilly Diabetes and Disney Publishing Worldwide Expand Collaboration
April 30, 2013
Custom Publications Will be Delivered to Families Affected by Type 1 Diabetes Throughout the World Read More
from PR Newswire
The Real Story Behind LLY, MHP, DHI and NOV
April 30, 2013
from Marketwired News Releases
Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams
April 26, 2013
Employees will serve in communities in need, including Johannesburg, South Africa, where they will support Lilly's diabetes partnership with Project HOPE Read More
from PR Newswire
Free Research Reports on LLY, T, WHR and YUM Issued by the Paragon Report
April 25, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Lilly Again Named One of DiversityInc's Top 50 Companies for Diversity
April 24, 2013
from PR Newswire
Lilly Reports First-Quarter 2013 Results
April 24, 2013
from PR Newswire
Lilly Acquires Novel Tau Tangle Diagnostic Program to Bolster Alzheimer's Disease Research and Development
April 17, 2013
Investment is an Important Advancement in the Company's Long-term Commitment to Bringing New Medicines to Millions of Alzheimer's Disease Patients Who Are Waiting Read More
from PR Newswire
Lilly Announces Positive Results of Phase III Trials of Dulaglutide in Type 2 Diabetes
April 16, 2013
Company Shares Top-line Results on Two Additional AWARD Trials, Both of which Examined Efficacy Compared to Insulin Glargine Read More
from PR Newswire
Lilly Debuts Early Oncology Pipeline Data At AACR Annual Meeting
April 10, 2013
Diverse pipeline reflected in four molecules targeting key cancer pathways Read More
from PR Newswire
Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures
April 04, 2013
from PR Newswire
Lilly Confirms Date and Conference Call for First-Quarter 2013 Financial Results Announcement
April 03, 2013
from PR Newswire
Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations
April 02, 2013
$180 million investment would support growing diabetes care need Read More
from PR Newswire
Today's Analysis on Bristol-Myers Squibb, Eli Lilly & Co., Endo Pharma, and Allergan
March 28, 2013
from PR Newswire
Perfect Trade Setups, How to Play LLY, APC, UTX and CELG
March 27, 2013
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here